Global Human Growth Hormone Drugs Market Status and Outlook 2018-2025

August 2018 | 141 pages | ID: GEE414E3555EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Eli Lilly and Company (US)
• Ferring Holding SA (Switzerland)
• Genentech, Inc. (US)
• GeneScience Pharmaceuticals Co., Ltd. (China)
• Merck KgaA (Germany)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (US)
• Sandoz International GmbH (Germany)

Market by Type

• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope - the Somatropin Biosimilar
• Somatropin Biopartners

Market by Application

• Prader-Willi Syndrome
• Turner Syndrome
• Short Stature Homeobox Gene
• Small for Gestational Age
• Chronic Renal Insufficiency
• Short Bowel Syndrome

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Human Growth Hormone Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Norditropin
  3.1.2 Genotropin
  3.1.3 Humatrope
  3.1.4 Saizen
  3.1.5 Omnitrope - the Somatropin Biosimilar
  3.1.6 Somatropin Biopartners
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Prader-Willi Syndrome
  4.1.2 Turner Syndrome
  4.1.3 Short Stature Homeobox Gene
  4.1.4 Small for Gestational Age
  4.1.5 Chronic Renal Insufficiency
  4.1.6 Short Bowel Syndrome
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Norditropin Production by Region
    6.1.1.2 Genotropin Production by Region
    6.1.1.3 Humatrope Production by Region
    6.1.1.4 Saizen Production by Region
    6.1.1.5 Omnitrope - the Somatropin Biosimilar Production by Region
    6.1.1.6 Somatropin Biopartners Production by Region
  6.1.2 Production by Application
    6.1.2.1 Prader-Willi Syndrome Production by Region
    6.1.2.2 Turner Syndrome Production by Region
    6.1.2.3 Short Stature Homeobox Gene Production by Region
    6.1.2.4 Small for Gestational Age Production by Region
    6.1.2.5 Chronic Renal Insufficiency Production by Region
    6.1.2.6 Short Bowel Syndrome Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Norditropin Demand by Region
    6.2.1.2 Genotropin Demand by Region
    6.2.1.3 Humatrope Demand by Region
    6.2.1.4 Saizen Demand by Region
    6.2.1.5 Omnitrope - the Somatropin Biosimilar Demand by Region
    6.2.1.6 Somatropin Biopartners Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Prader-Willi Syndrome Demand by Region
    6.2.2.2 Turner Syndrome Demand by Region
    6.2.2.3 Short Stature Homeobox Gene Demand by Region
    6.2.2.4 Small for Gestational Age Demand by Region
    6.2.2.5 Chronic Renal Insufficiency Demand by Region
    6.2.2.6 Short Bowel Syndrome Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Eli Lilly and Company (US)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Ferring Holding SA (Switzerland)
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Genentech, Inc. (US)
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 GeneScience Pharmaceuticals Co., Ltd. (China)
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Merck KgaA (Germany)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Novo Nordisk A/S (Denmark)
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Pfizer, Inc. (US)
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Sandoz International GmbH (Germany)
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Human Growth Hormone Drugs Industry Dynamics & Regulations List
Table Global Human Growth Hormone Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Human Growth Hormone Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Human Growth Hormone Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Human Growth Hormone Drugs Market Status by Application 2015-2018E, in Volume
Table Global Human Growth Hormone Drugs Market by Region 2015-2018E, in USD Million
Table Global Human Growth Hormone Drugs Market Share by Region in 2018, in USD Million
Table Global Human Growth Hormone Drugs Market by Region 2015-2018E, in Volume
Table Global Human Growth Hormone Drugs Market Share by Region in 2018, in Volume
Table Norditropin Production Value by Region 2015-2018E, in USD Million
Table Norditropin Production Volume by Region 2015-2018E, in Volume
Table Genotropin Production Value by Region 2015-2018E, in USD Million
Table Genotropin Production Volume by Region 2015-2018E, in Volume
Table Humatrope Production Value by Region 2015-2018E, in USD Million
Table Humatrope Production Volume by Region 2015-2018E, in Volume
Table Saizen Production Value by Region 2015-2018E, in USD Million
Table Saizen Production Volume by Region 2015-2018E, in Volume
Table Omnitrope - the Somatropin Biosimilar Production Value by Region 2015-2018E, in USD Million
Table Omnitrope - the Somatropin Biosimilar Production Volume by Region 2015-2018E, in Volume
Table Somatropin Biopartners Production Value by Region 2015-2018E, in USD Million
Table Somatropin Biopartners Production Volume by Region 2015-2018E, in Volume
Table Prader-Willi Syndrome Production Value by Region 2015-2018E, in USD Million
Table Prader-Willi Syndrome Production Volume by Region 2015-2018E, in Volume
Table Turner Syndrome Production Value by Region 2015-2018E, in USD Million
Table Turner Syndrome Production Volume by Region 2015-2018E, in Volume
Table Short Stature Homeobox Gene Production Value by Region 2015-2018E, in USD Million
Table Short Stature Homeobox Gene Production Volume by Region 2015-2018E, in Volume
Table Small for Gestational Age Production Value by Region 2015-2018E, in USD Million
Table Small for Gestational Age Production Volume by Region 2015-2018E, in Volume
Table Chronic Renal Insufficiency Production Value by Region 2015-2018E, in USD Million
Table Chronic Renal Insufficiency Production Volume by Region 2015-2018E, in Volume
Table Short Bowel Syndrome Production Value by Region 2015-2018E, in USD Million
Table Short Bowel Syndrome Production Volume by Region 2015-2018E, in Volume
Table Norditropin Market Size by Region 2015-2018E, in USD Million
Table Norditropin Market Size by Region 2015-2018E, in Volume
Table Genotropin Market Size by Region 2015-2018E, in USD Million
Table Genotropin Market Size by Region 2015-2018E, in Volume
Table Humatrope Market Size by Region 2015-2018E, in USD Million
Table Humatrope Market Size by Region 2015-2018E, in Volume
Table Saizen Market Size by Region 2015-2018E, in USD Million
Table Saizen Market Size by Region 2015-2018E, in Volume
Table Omnitrope - the Somatropin Biosimilar Market Size by Region 2015-2018E, in USD Million
Table Omnitrope - the Somatropin Biosimilar Market Size by Region 2015-2018E, in Volume
Table Somatropin Biopartners Market Size by Region 2015-2018E, in USD Million
Table Somatropin Biopartners Market Size by Region 2015-2018E, in Volume
Table Prader-Willi Syndrome Market Size by Region 2015-2018E, in USD Million
Table Prader-Willi Syndrome Market Size by Region 2015-2018E, in Volume
Table Turner Syndrome Market Size by Region 2015-2018E, in USD Million
Table Turner Syndrome Market Size by Region 2015-2018E, in Volume
Table Short Stature Homeobox Gene Market Size by Region 2015-2018E, in USD Million
Table Short Stature Homeobox Gene Market Size by Region 2015-2018E, in Volume
Table Small for Gestational Age Market Size by Region 2015-2018E, in USD Million
Table Small for Gestational Age Market Size by Region 2015-2018E, in Volume
Table Chronic Renal Insufficiency Market Size by Region 2015-2018E, in USD Million
Table Chronic Renal Insufficiency Market Size by Region 2015-2018E, in Volume
Table Short Bowel Syndrome Market Size by Region 2015-2018E, in USD Million
Table Short Bowel Syndrome Market Size by Region 2015-2018E, in Volume
Table GlobalHuman Growth Hormone Drugs Forecast by Type 2019F-2025F, in USD Million
Table Human Growth Hormone Drugs Forecast by Type 2019F-2025F, in Volume
Table Human Growth Hormone Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Human Growth Hormone Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Human Growth Hormone Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Human Growth Hormone Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Eli Lilly and Company (US) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Eli Lilly and Company (US)
Table Ferring Holding SA (Switzerland) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Ferring Holding SA (Switzerland)
Table Genentech, Inc. (US) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Genentech, Inc. (US)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of GeneScience Pharmaceuticals Co., Ltd. (China)
Table Merck KgaA (Germany) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Merck KgaA (Germany)
Table Novo Nordisk A/S (Denmark) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Novo Nordisk A/S (Denmark)
Table Pfizer, Inc. (US) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Pfizer, Inc. (US)
Table Sandoz International GmbH (Germany) Information
Table Human Growth Hormone Drugs Sales, Cost, Margin of Sandoz International GmbH (Germany)
Table Global Human Growth Hormone Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Human Growth Hormone Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Human Growth Hormone Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Human Growth Hormone Drugs Picture
Figure Human Growth Hormone Drugs Industry Chain Diagram
Figure Global Human Growth Hormone Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Human Growth Hormone Drugs Sales Volume 2015-2018E, in Volume
Figure Global Human Growth Hormone Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Human Growth Hormone Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Human Growth Hormone Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Human Growth Hormone Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Human Growth Hormone Drugs Sales Price Forecast 2019F-2025F
Figure Global Human Growth Hormone Drugs Gross Margin Forecast 2019F-2025F
Figure Global Human Growth Hormone Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Human Growth Hormone Drugs Price by Company in 2018
Figure Global Human Growth Hormone Drugs Gross Margin by Company in 2018